Transcatheter valve-in-valve implantation for failing bioprosthetic valves

2010 ◽  
Vol 6 (6) ◽  
pp. 811-831 ◽  
Author(s):  
Ali N Azadani ◽  
Elaine E Tseng
2017 ◽  
Vol 65 (S 01) ◽  
pp. S1-S110
Author(s):  
L.O. Conzelmann ◽  
H. Schröfel ◽  
A. Würth ◽  
P. Tzamalis ◽  
P. Bramlage ◽  
...  

2018 ◽  
Vol 108 (1) ◽  
pp. 117-117
Author(s):  
Bernhard Wernly ◽  
Ann-Katrin Zappe ◽  
Axel Unbehaun ◽  
Jan-Malte Sinning ◽  
Christian Jung ◽  
...  

2015 ◽  
Vol 16 (2) ◽  
pp. 96 ◽  
Author(s):  
Ziv Beckerman ◽  
Oved Cohen ◽  
Arthur Kerner ◽  
Ariel Roguin ◽  
Avishai Ziser ◽  
...  

The strategy of transcatheter valve-in-valve implantation into failing mitral and aortic bioprosthetic valves is a documented approach. It allows one to avoid performing a high-risk repeat cardiac surgery in elderly patients with multiple comorbidities. Tricuspid valve-in-valve implantation has been documented only a few times in the literature. We report the case of a 65-year-old woman with a failing bioprosthetic tricuspid valve who had undergone 3 prior open heart operations. We attempted a transatrial transcatheter approach and successfully deployed a 29-mm Edwards Sapien balloon-expandable bioprosthesis into a severely stenotic tricuspid bioprosthesis. This case demonstrates the technical feasibility and safety of this approach.


2018 ◽  
Vol 108 (1) ◽  
pp. 83-92 ◽  
Author(s):  
Bernhard Wernly ◽  
Ann-Katrin Zappe ◽  
Axel Unbehaun ◽  
Jan-Malte Sinning ◽  
Christian Jung ◽  
...  

2011 ◽  
Vol 58 (21) ◽  
pp. 2196-2209 ◽  
Author(s):  
Ronen Gurvitch ◽  
Anson Cheung ◽  
Jian Ye ◽  
David A. Wood ◽  
Alexander B. Willson ◽  
...  

2020 ◽  
Vol 26 (1) ◽  
pp. 135
Author(s):  
A. B. Voevodin ◽  
A. A. Allenov ◽  
V. V. Bazylev

2020 ◽  
Vol 3 (10) ◽  
pp. 01-05
Author(s):  
Marco Angelillis

Transcatheter valve in valve (ViV) implantation actually represents a valid alternative to surgical reinterventions in patients with previous surgical aortic valve replacement (AVR). In patients less than 80 years old, it is crucial to correctly position the new valve leaving a feasible and easy access to coronary ostia, both for future percutaneous coronary intervention (PCI) than for a future possible TAVinTAV procedure. We report a 71 year old man with prior AVR presented with structural valve deterioration (SVD) leading to severe aortic stenosis. In order to guarantee comfortable coronary access we aligned, the commissures of the new percutaneous valve with the ones of the surgical bioprothesis by reconstructing the headframes of the surgical bioprosthesis with computer tomography (CT) and fluoro-CT.


Sign in / Sign up

Export Citation Format

Share Document